These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7904943

  • 1. Effect of dietary protein on the renal response to fenoldopam in diabetic rats.
    Wang YX, Brooks DP.
    Eur J Pharmacol; 1993 Oct 01; 248(3):217-21. PubMed ID: 7904943
    [Abstract] [Full Text] [Related]

  • 2. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX, Gellai M, Brooks DP.
    Am J Physiol; 1992 Jun 01; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [Abstract] [Full Text] [Related]

  • 3. Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
    Barthelmebs M, Vailly B, Grima M, Velly J, Stephan D, Froehly S, Imbs JL.
    J Cardiovasc Pharmacol; 1991 Aug 01; 18(2):243-53. PubMed ID: 1717786
    [Abstract] [Full Text] [Related]

  • 4. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL, Smith FG, Guillery EN, Jose PA, Robillard JE.
    Am J Physiol; 1992 Oct 01; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [Abstract] [Full Text] [Related]

  • 5. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ, Apparsundaram S, Lokhandwala MF.
    J Pharmacol Exp Ther; 1991 Feb 01; 256(2):486-91. PubMed ID: 1671595
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI, Smith GW.
    J Pharmacol Exp Ther; 1994 Feb 01; 268(2):565-70. PubMed ID: 7906731
    [Abstract] [Full Text] [Related]

  • 7. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
    Pollock DM, Arendshorst WJ.
    Am J Physiol; 1990 Mar 01; 258(3 Pt 2):F627-35. PubMed ID: 1969238
    [Abstract] [Full Text] [Related]

  • 8. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J.
    J Clin Endocrinol Metab; 1989 Dec 01; 69(6):1116-21. PubMed ID: 2573613
    [Abstract] [Full Text] [Related]

  • 9. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW, Comans EF, de Vries PM, Oe PL, Roos JC, Smit AJ, Streurman O, Donker AJ.
    Neth J Med; 1990 Jun 01; 36(5-6):267-78. PubMed ID: 1975651
    [Abstract] [Full Text] [Related]

  • 10. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS, Ricci A, Amenta F, Lokhandwala MF.
    J Pharmacol Exp Ther; 1989 Dec 01; 251(3):1237-45. PubMed ID: 2574743
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
    Häberle DA, Königbauer B.
    J Physiol; 1991 Sep 01; 441():23-34. PubMed ID: 1687747
    [Abstract] [Full Text] [Related]

  • 12. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors.
    Bakris GL, Lass NA, Glock D.
    Kidney Int; 1999 Jul 01; 56(1):206-10. PubMed ID: 10411694
    [Abstract] [Full Text] [Related]

  • 13. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB, Mann WA, Weinstock J, Ruffolo RR.
    Chirality; 1994 Jul 01; 6(5):446-55. PubMed ID: 7915128
    [Abstract] [Full Text] [Related]

  • 14. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
    Yatsu T, Arai Y, Takizawa K, Kasai-Nakagawa C, Takanashi M, Uchida W, Inagaki O, Tanaka A, Asano M, Honda K, Takenaka T.
    Eur J Pharmacol; 1997 Mar 12; 322(1):45-53. PubMed ID: 9088869
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
    Brooks DP, DePalma PD, Cyronak MJ, Karpinski K, Weinstock J.
    Pharmacology; 1990 Mar 12; 41(5):299-308. PubMed ID: 1982634
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
    Chen C, Lokhandwala MF.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar 12; 347(3):289-95. PubMed ID: 8097567
    [Abstract] [Full Text] [Related]

  • 17. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.
    Allison NL, Dubb JW, Ziemniak JA, Alexander F, Stote RM.
    Clin Pharmacol Ther; 1987 Mar 12; 41(3):282-8. PubMed ID: 2880688
    [Abstract] [Full Text] [Related]

  • 18. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL, Hilditch A, Robertson MJ, Drew GM.
    J Hypertens; 1991 Dec 12; 9(12):1143-50. PubMed ID: 1685741
    [Abstract] [Full Text] [Related]

  • 19. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
    Horton R, Bughi S, Jost-Vu E, Antonipillai I, Nadler J.
    Am J Hypertens; 1990 Jun 12; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM.
    Eur J Pharmacol; 1986 Jul 15; 126(1-2):167-70. PubMed ID: 2875883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.